| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26 |
| filingDate |
1994-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b254223a14c3777adf9ae02cbd41400 |
| publicationDate |
2002-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6489288-B1 |
| titleOfInvention |
Treatment of polycystic ovarian disease |
| abstract |
Agents which increase the levels of human insulin-like growth factor—1 binding protein (h-IGFBP-1), such as an estrogen, are used in conjunction with a gonadotropin releasing hormone (GnRH) analogue in the treatment of PCOD and associated infertility. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004053813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6750141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7259143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008249068-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7671027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006069031-A1 |
| priorityDate |
1990-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |